In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria
- 1 March 1981
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 19 (3), 490-492
- https://doi.org/10.1128/aac.19.3.490
Abstract
The in vitro activities of four new beta-lactam antibiotics and dibekacin against aerobic bacteria were compared. The new cephalosporins were more broadly active against gram-negative bacteria than were presently available cephalosporins, but were less active against staphylococci.Keywords
This publication has 5 references indexed in Scilit:
- In vitro evaluation of cefoperazoneAntimicrobial Agents and Chemotherapy, 1980
- Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolatesAntimicrobial Agents and Chemotherapy, 1980
- LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1979
- Comparative Evaluation of Piperacillin in VitroAntimicrobial Agents and Chemotherapy, 1978
- In Vitro Comparison of Kanamycin, Kanendomycin, Gentamicin, Amikacin, Sisomicin, and Dibekacin Against 200 Strains of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1978